Preemptive mitigation of CD19 CAR T-cell cytokine release syndrome without attenuation of antileukemic efficacyRebecca Gardner, Michael C. Jensen, Francesco Ceppi et al.|Blood|2019Cited by 287
Lymphocyte apheresis for chimeric antigen receptor T‐cell manufacturing in children and young adults with leukemia and neuroblastomaFrancesco Ceppi, Rebecca Gardner, Catherine Lindgren et al.|Transfusion|2018Cited by 93
Early Clinical Experience of CD19 x CD22 Dual Specific CAR T Cells for Enhanced Anti-Leukemic Targeting of Acute Lymphoblastic LeukemiaRebecca Gardner, Michael C. Jensen, Colleen Annesley et al.|Blood|2018Cited by 65
Novel CD19t T-Antigen Presenting Cells Expand CD19 CAR T Cells In VivoColleen Annesley, Michael C. Jensen, Rebecca Gardner et al.|Blood|2019Cited by 20
Early Response Data for Pediatric Patients with Non-Hodgkin Lymphoma Treated with CD19 Chimeric Antigen Receptor (CAR) T-CellsJulie Rivers, Rebecca Gardner, Colleen Annesley et al.|Blood|2018Cited by 19